Macropinocytosis in Cancer: A Complex Signaling Network.


Journal

Trends in cancer
ISSN: 2405-8025
Titre abrégé: Trends Cancer
Pays: United States
ID NLM: 101665956

Informations de publication

Date de publication:
06 2019
Historique:
received: 22 03 2019
revised: 10 04 2019
accepted: 11 04 2019
entrez: 19 6 2019
pubmed: 19 6 2019
medline: 2 7 2020
Statut: ppublish

Résumé

Macropinocytosis is an important nutrient-scavenging pathway in numerous cancer types, including pancreatic, lung, prostate, and bladder. This Forum highlights recent work identifying the key regulators of macropinocytosis that support tumor cell fitness in different contexts, providing a unique framework for strategies to target macropinocytosis in the treatment of cancer.

Identifiants

pubmed: 31208695
pii: S2405-8033(19)30072-X
doi: 10.1016/j.trecan.2019.04.002
pmc: PMC7325493
mid: NIHMS1600460
pii:
doi:

Substances chimiques

Biomarkers, Tumor 0

Types de publication

Letter Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

332-334

Subventions

Organisme : NCI NIH HHS
ID : R01 CA207189
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Références

Mol Biol Cell. 2000 Oct;11(10):3453-67
pubmed: 11029048
Front Physiol. 2014 Sep 30;5:374
pubmed: 25324782
Cancer Discov. 2018 Jul;8(7):866-883
pubmed: 29572236
Nature. 2013 May 30;497(7451):633-7
pubmed: 23665962
J Cell Sci. 1996 Aug;109 ( Pt 8):2005-12
pubmed: 8856496
Science. 1986 Sep 5;233(4768):1061-8
pubmed: 3090687
J Cell Sci. 2016 Apr 1;129(7):1287-92
pubmed: 26985062
Cancer Discov. 2017 Dec;7(12):1464-1479
pubmed: 28893801
Traffic. 2009 Apr;10(4):364-71
pubmed: 19192253
Front Endocrinol (Lausanne). 2017 Sep 29;8:261
pubmed: 29085336
Cancer Res. 2013 Feb 1;73(3):1156-67
pubmed: 23378476
Cell. 2015 Jul 16;162(2):259-270
pubmed: 26144316
Nat Cell Biol. 2014 May;16(5):457-68
pubmed: 24747441
Cancer Res. 2018 Aug 15;78(16):4658-4670
pubmed: 29871936

Auteurs

Yijuan Zhang (Y)

Tumor Initiation and Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.

Cosimo Commisso (C)

Tumor Initiation and Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA. Electronic address: ccommisso@sbpdiscovery.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH